Presentation is loading. Please wait.

Presentation is loading. Please wait.

Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study  Tiago Nunes, Manuel.

Published byMaría del Rosario Serrano García Modified over 6 years ago

Similar presentations

Presentation on theme: "Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study  Tiago Nunes, Manuel."— Presentation transcript:

1 Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study  Tiago Nunes, Manuel Barreiro-de Acosta, Pilar Nos, Ignacio Marin-Jiménez, Fernando Bermejo, Daniel Ceballos, Eva Iglesias, Silvia Gomez-Senent, Yolanda Torres, Angel Ponferrada, José A. Arevalo, Vicent Hernandez, Xavier Calvet, Daniel Ginard, David Monfort, Maria Chaparro, Noemi Manceñido, Mercedes Domínguez-Antonaya, César Villalón, José L. Perez-Calle, Carmen Muñoz, Henar Nuñez, Daniel Carpio, Roberto Aramendiz, Luis Bujanda, Silvia Estrada-Oncins, Carlos Hermida, Jesus Barrio, Mª Begoña Casis, Ma Carmen Dueñas-Sadornil, Luis Fernández, Mª Mar Calvo-Cenizo, Belen Botella, Ruth de Francisco, Edgar Ayala, Miquel Sans  Journal of Crohn's and Colitis  Volume 4, Issue 6, Pages (December 2010) DOI: /j.crohns Copyright © 2010 European Crohn's and Colitis Organisation Terms and Conditions

2 Figure 1 BDP dose and treatment duration. A) Percentage of patients treated with each BDP dose. B) Percentage of patients according to duration of BDP treatment. Journal of Crohn's and Colitis 2010 4, DOI: ( /j.crohns ) Copyright © 2010 European Crohn's and Colitis Organisation Terms and Conditions

3 Figure 2 Other treatment changes at BDP start. Each bar represents the percentage of patients in which treatment was modified when BDP was started. Journal of Crohn's and Colitis 2010 4, DOI: ( /j.crohns ) Copyright © 2010 European Crohn's and Colitis Organisation Terms and Conditions

4 Figure 3 BDP efficacy. A) Global efficacy of BDP treatment: each bar represents the percentage of patients achieving remission, response or failure under BDP treatment; B) Mayo score pre/post BDP treatment: box plot graphic displays the distribution of pMS before and after BDP treatment. Journal of Crohn's and Colitis 2010 4, DOI: ( /j.crohns ) Copyright © 2010 European Crohn's and Colitis Organisation Terms and Conditions

5 Figure 4 Factors influencing BDP-induced remission. Bars represent the percentage of patients that achieved remission under BDP treatment, according to UC severity (A), extension (B), maintenance treatment (C) and changes in treatment (D). Journal of Crohn's and Colitis 2010 4, DOI: ( /j.crohns ) Copyright © 2010 European Crohn's and Colitis Organisation Terms and Conditions

6 Figure 5 Efficacy of BDP treatment according to dose and therapy duration. Bars represent the percentage of patients that achieved remission, response or failure according to A) BDP dose and B) treatment duration. Journal of Crohn's and Colitis 2010 4, DOI: ( /j.crohns ) Copyright © 2010 European Crohn's and Colitis Organisation Terms and Conditions

7 Figure 6 Rescue therapy after BDP treatment. Each bar represents the percentage of patients receiving different medical rescue therapies or requiring colectomy. Journal of Crohn's and Colitis 2010 4, DOI: ( /j.crohns ) Copyright © 2010 European Crohn's and Colitis Organisation Terms and Conditions

Download ppt "Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study  Tiago Nunes, Manuel."

Similar presentations

Volume 65, Issue 3, Pages (September 2016)

Volume 65, Issue 3, Pages (September 2016)
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front- line therapy with novel agents combinations  Aurelio Lopez, Maria-Victoria.

Patterns of relapse and outcome of elderly multiple myeloma patients treated as front- line therapy with novel agents combinations  Aurelio Lopez, Maria-Victoria.
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.
IBD in the elderly population: Results from a population-based study in Western Hungary, 1977���2008  Peter Laszlo Lakatos, Gyula David, Tunde Pandur,

IBD in the elderly population: Results from a population-based study in Western Hungary, 1977���2008  Peter Laszlo Lakatos, Gyula David, Tunde Pandur,
How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,
Serta Kılınçalp, Akif Altınbaş, Ömer Başar, Murat Deveci, Osman Yüksel 

Serta Kılınçalp, Akif Altınbaş, Ömer Başar, Murat Deveci, Osman Yüksel 
Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?  Tamás Molnár, Klaudia Farkas, Ferenc.

Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?  Tamás Molnár, Klaudia Farkas, Ferenc.
Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? 

Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? 
Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events  Fernando Magro, Manuel.

Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events  Fernando Magro, Manuel.
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
YouTube® and inflammatory bowel disease

YouTube® and inflammatory bowel disease
Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report  Andreia Albuquerque, Fernando Magro,

Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report  Andreia Albuquerque, Fernando Magro,
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
High smoking cessation rate in Crohn's disease patients after physician advice – The TABACROHN Study  Tiago Nunes, Maria Josefina Etchevers, Olga Merino,

High smoking cessation rate in Crohn's disease patients after physician advice – The TABACROHN Study  Tiago Nunes, Maria Josefina Etchevers, Olga Merino,
Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series  Erik Mooiweer,

Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series  Erik Mooiweer,
Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)  Mariam Aguas, Vicente Garrigues,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)  Mariam Aguas, Vicente Garrigues,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 

Similar presentations

Ads by Google